New Therapies Pose Quandary for Medicare: "But health economists and medical experts say the treatment, however alluring, is part of an unsettling trend: new and ever pricier treatments for common medical conditions that are part and parcel of aging ... procedures that could potentially benefit tens of thousands of patients, at a total cost that would far exceed the kind of prescription drug benefit now being considered by Congress. "
In the future the wealthy will get first dibs on new therapies. This may be a mixed blessing, new stuff is often risky. The rest of us will get it when development costs are paid.
No comments:
Post a Comment